JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 2. Tumor versus kidney uptake. Radiolabeled DOTA-{alpha}-MSH analogs ({blacksquare}, 111In-DOTA-MSHoct; {square}, 111In-DOTA-NAPamide; , 67Ga-DOTA-NAPamide) were injected into melanoma-bearing mice and radioactivity accumulated in tumor and kidney was measured 4, 24, and 48 h after injection. Results are expressed as tumor AUC (left), kidney AUC (middle), and tumor-to-kidney ratios of AUC (right) (n = 8).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE